Home/Investors/Oxford Science Enterprises

Oxford Science Enterprises

Biotech Investor · 2 portfolio companies

Portfolio
2
Focus Areas
3
Top Stage
Pre-clinical

Portfolio Companies

CompanyValuation
Scripta Therapeutics
EndLyz Therapeutics